Background: Immune checkpoint inhibitor (ICI) therapy is an effective treatment for many patients. Although rare, immune-mediated cardiovascular adverse events can occur, including myocarditis. Objectives: This article provides an overview of the incidence, proposed pathophysiology, and current...